Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya
TASCO
Male Circumcision for HIV Prevention in Kenya: Seeking Effective Strategies to Recruit Older Men
1 other identifier
interventional
2,785
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of two interventions - Inter-Personal Communication \[IPC\] and Dedicated Service Outlets \[DSOs\] - in recruiting men aged 25-39 years for Voluntary Medical Male Circumcision (VMMC) services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 20, 2015
CompletedFirst Posted
Study publicly available on registry
July 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2016
CompletedMarch 12, 2018
March 1, 2018
11 months
May 20, 2015
March 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of uptake of VMMC services among men in 4 study arms
We will assess the rate of uptake of VMMC services by men aged 25-39 years exposed to (i) Inter-personal communication (IPC) intervention vs. (ii) Designated (older men only) Service Outlets (DSO) intervention vs. (iii) IPC and DSO interventions combined vs. (iv) No intervention.
Three months post intervention
Secondary Outcomes (1)
Prevalence of HIV among VMMC clients who decline HIV testing
Three months post intervention
Other Outcomes (2)
Cost of VMMC demand creation
Nine months
Role of female sexual partners in time to resumption of sex post circumcision
Nine months
Study Arms (4)
Inter-personal Communication (IPC)
EXPERIMENTALInterpersonal communication will entail delivery of intervention massages that are custom-made to address individual participants' specific barriers and facilitators of VMMC. RAs will discuss with uncircumcised men why they have not gone for VMMC using the 'VMMC Demand Creation Toolkit'. The aim will be to fully address their barriers and re-enforce their facilitators. RAS will be trained behavioral counselors, circumcised men, female partners, CHWs, or any other cadre of individuals identified during the formative phase.
Dedicated Service Outlets (DSO)
EXPERIMENTALRAs shall visit all households with eligible men to inform them about the availability of, and give information on location of DSO sites in the Location. DSOs are sites: where services are offered exclusively to men aged ≥25 years by male service providers in the same age bracket; providing services in the evenings/weekends/designated days of the week, and through special mobile services for older men. DSO sites we will strive to shorten the waiting time to ≤ three hours. They will be informed that all other VMMC sites continue to serve all men regardless of age (i.e., including older men) while DSO sites will only serve men aged ≥25 years. RAs will respond to questions using 'All You Need to Know About VMMC' booklet, the same way current recruiters do.
Combined IPC & DSO
EXPERIMENTALBoth Inter-personal Communication (IPC) and Dedicated Service Outlets (DSO) interventions (as described above) will be implemented concurrently. This will be done to determine the effect of both interventions delivered jointly compared to each delivered singly, and compared to no intervention.
Control
NO INTERVENTIONIn these Locations, participants will only be given the 'All You Need to Know About VMMC' booklet at the time of enrollment, which is the standard of care.
Interventions
RAs will meet older men in their households, and : i) approach the person(s), introduce self, develop rapport and request for time to discuss briefly about VMMC; ii) strike a conversation on reasons why they or their peers have not gone to be circumcised as well as reasons that would make them get circumcised, jotting down responses to guide the discussion; iii) using the 'VMMC Demand Creation Toolkit', discuss each reported barrier/facilitator carefully and completely, always ensuring the person(s) is/are engaged in the discussion (the goal is to pass correct and complete information in a relaxed and conversational manner); iv) revisiting each stated barrier/barrier and exploring what they now think about them after the discussion, and address any new or lingering concerns.
RAs shall visit every household with eligible men to inform them about the availability of DSO sites in their neighborhoods. After describing the characteristics of DSO sites, the RA will share - both verbally and through a flyer, information on where to find DSO sites in the respective Location. RAs will respond to questions using 'All You Need to Know About VMMC' booklet, the same way current recruiters do. They will also inform potential participants that all other VMMC sites continue to serve all men regardless of age (i.e., including older men) while DSO sites will only serve men aged ≥25 years.
Eligibility Criteria
You may qualify if:
- Uncircumcised men
- Aged 25 - 39 years
- Residents of the study village (has been living in the physical structure such as a compound or homestead identified during the enumeration and who has been consuming or making some contribution to food and other shared household resources).
- Intend to continue living in the village for the 9 months after enrollment, which is the estimated duration of data collection.
- Give written consent to participate in the study and the interventions.
You may not qualify if:
- Circumcised men
- Aged \<25- or \>39 years
- Non-resident of target villages
- Plans to move away from the village within 9 months after enrollment
- Does not give consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Impact Research & Development Organizationlead
- Centers for Disease Control and Preventioncollaborator
- Kenya Ministry of Healthcollaborator
Study Sites (1)
Impact Research and Development Organization
Kisumu, Nyanza, 40141, Kenya
Related Publications (33)
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298. doi: 10.1371/journal.pmed.0020298. Epub 2005 Oct 25.
PMID: 16231970BACKGROUNDBailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643-56. doi: 10.1016/S0140-6736(07)60312-2.
PMID: 17321310BACKGROUNDGray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369(9562):657-66. doi: 10.1016/S0140-6736(07)60313-4.
PMID: 17321311BACKGROUNDWeiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008 Mar 12;22(5):567-74. doi: 10.1097/QAD.0b013e3282f3f406. No abstract available.
PMID: 18316997BACKGROUNDSiegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003362. doi: 10.1002/14651858.CD003362.pub2.
PMID: 19370585BACKGROUNDUNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009 Sep;6(9):e1000109. doi: 10.1371/journal.pmed.1000109. Epub 2009 Sep 8.
PMID: 19901974BACKGROUNDWeiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000 Oct 20;14(15):2361-70. doi: 10.1097/00002030-200010200-00018.
PMID: 11089625BACKGROUNDNagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007 Mar 13;7:16. doi: 10.1186/1471-2334-7-16.
PMID: 17355625BACKGROUNDNjeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, Castor D, Stover J, Farley T, Menon V, Hankins C. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011 Nov;8(11):e1001132. doi: 10.1371/journal.pmed.1001132. Epub 2011 Nov 29.
PMID: 22140367BACKGROUNDBailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ. 2008 Sep;86(9):669-77. doi: 10.2471/blt.08.051482.
PMID: 18797642BACKGROUNDRennie S, Muula AS, Westreich D. Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. J Med Ethics. 2007 Jun;33(6):357-61. doi: 10.1136/jme.2006.019901.
PMID: 17526688BACKGROUNDHerman-Roloff A, Otieno N, Agot K, Ndinya-Achola J, Bailey RC. Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One. 2011;6(5):e19814. doi: 10.1371/journal.pone.0019814. Epub 2011 May 16.
PMID: 21603622BACKGROUNDNgalande RC, Levy J, Kapondo CP, Bailey RC. Acceptability of male circumcision for prevention of HIV infection in Malawi. AIDS Behav. 2006 Jul;10(4):377-85. doi: 10.1007/s10461-006-9076-8.
PMID: 16736112BACKGROUNDIvers NM, Taljaard M, Dixon S, Bennett C, McRae A, Taleban J, Skea Z, Brehaut JC, Boruch RF, Eccles MP, Grimshaw JM, Weijer C, Zwarenstein M, Donner A. Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8. BMJ. 2011 Sep 26;343:d5886. doi: 10.1136/bmj.d5886.
PMID: 21948873BACKGROUNDMarya Plotkin, Hawa Mziray, Jan Küver Judith Prince, et al (2011). Embe Halijamenywa: The unpeeled mango: A Qualitative Assessment of Views and Preferences concerning Voluntary Voluntary Medical Male Circumcision in Iringa Region, Tanzania.
BACKGROUNDKNBS (2010) 2009 Kenya Population and Housing Census, Volume I A; Population by Administrative Units, Kenya National Bureau of Statistics, Nairobi, Kenya
BACKGROUNDE.Odoyo-June , J H Rogers, W Jaoko, et al. Sex before wound healing and condom use among newly circumcised HIV-positive and HIV-negative men in Kisumu, Kenya. 19th International AIDS Conference. Abstract no MOPE170
BACKGROUNDCzarnogorski M, Brown J, Lee V, Oben J, Kuo I, Stern R, Simon G. The Prevalence of Undiagnosed HIV Infection in Those Who Decline HIV Screening in an Urban Emergency Department. AIDS Res Treat. 2011;2011:879065. doi: 10.1155/2011/879065. Epub 2011 May 9.
PMID: 21738860BACKGROUNDWeinstock H, Dale M, Linley L, Gwinn M. Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health. 2002 Feb;92(2):280-3. doi: 10.2105/ajph.92.2.280.
PMID: 11818306BACKGROUNDDukers-Muijrers NH, Niekamp AM, Vergoossen MM, Hoebe CJ. Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect. 2009 Jun;85(3):226-30. doi: 10.1136/sti.2008.033191. Epub 2008 Dec 22.
PMID: 19103641BACKGROUNDNational AIDS and STI Control Programme NASCOP (2008). Adapted by the Male Circumcision Task Force, Ministry of Health, Kenya, from the WHO/UNAIDS/JHPIEGO Manual for Male Circumcision under Local Anaesthesia. Version 2.5C, February 2008.
BACKGROUNDBertrand JT, Njeuhmeli E, Forsythe S, Mattison SK, Mahler H, Hankins CA. Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One. 2011;6(11):e27562. doi: 10.1371/journal.pone.0027562. Epub 2011 Nov 29.
PMID: 22140450BACKGROUNDBollinger L W, Plosky D, Stover J. (2009). Male circumcision: Decision Maker's Program Planning Tool, calculating the costs and Impacts of a Male Circumcision Program. Washington, DC: Futures Group, Health Policy Initiative , Task Order 1
BACKGROUNDKahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006 Dec;3(12):e517. doi: 10.1371/journal.pmed.0030517.
PMID: 17194197BACKGROUNDSchroeder E, Petrou S, Patel N, Hollowell J, Puddicombe D, Redshaw M, Brocklehurst P; Birthplace in England Collaborative Group. Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study. BMJ. 2012 Apr 18;344:e2292. doi: 10.1136/bmj.e2292.
PMID: 22517916BACKGROUNDGray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS. 2007 Apr 23;21(7):845-50. doi: 10.1097/QAD.0b013e3280187544.
PMID: 17415039BACKGROUNDTekeste A, Wondafrash M, Azene G, Deribe K. Cost effectiveness of community-based and in-patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Eff Resour Alloc. 2012 Mar 19;10:4. doi: 10.1186/1478-7547-10-4.
PMID: 22429892BACKGROUNDPrinja S, Bahuguna P, Rudra S, Gupta I, Kaur M, Mehendale SM, Chatterjee S, Panda S, Kumar R. Cost effectiveness of targeted HIV prevention interventions for female sex workers in India. Sex Transm Infect. 2011 Jun;87(4):354-61. doi: 10.1136/sti.2010.047829. Epub 2011 Mar 29.
PMID: 21447514BACKGROUNDEvans DB, Edejer TT, Adam T, Lim SS. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ. 2005 Nov 12;331(7525):1137-40. doi: 10.1136/bmj.331.7525.1137. No abstract available.
PMID: 16282411BACKGROUNDIoannidis JP, Garber AM. Individualized cost-effectiveness analysis. PLoS Med. 2011 Jul;8(7):e1001058. doi: 10.1371/journal.pmed.1001058. Epub 2011 Jul 12.
PMID: 21765810BACKGROUNDNational AIDS Control Council 2. (NACC), N.A.C.C., The Kenya National HIV/AIDS Strategic Plan 2010-2013 (KNASP III). 2009: Nairobi, Kenya.. (2009). The Kenya National HIV/AIDS Strategic Plan 2010 - 2013 (KNASP III). Ministry of Public Health and Sanitation, Nairobi, Kenya.
BACKGROUNDMale Circumcision Consortium 1. (MCC), M.C.C. 2011. News. December 2011; issue 33
BACKGROUNDGrund JM, Onchiri F, Mboya E, Ussery F, Musingila P, Ohaga S, Odoyo-June E, Bock N, Ayieko B, Agot K. Strategies to increase uptake of voluntary medical male circumcision among men aged 25-39 years in Nyanza Region, Kenya: Results from a cluster randomized controlled trial (the TASCO study). PLoS One. 2023 Feb 3;18(2):e0276593. doi: 10.1371/journal.pone.0276593. eCollection 2023.
PMID: 36735665DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kawango Agot, PhD, MPH
Impact Research and Development Organization
- PRINCIPAL INVESTIGATOR
Jonathan Grund, MA, MPH
Centers for Disease Control and Prevention
- STUDY DIRECTOR
Jacob Onyango
Impact Research and Development Organization
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
May 20, 2015
First Posted
July 15, 2015
Study Start
February 1, 2015
Primary Completion
January 1, 2016
Study Completion
January 22, 2016
Last Updated
March 12, 2018
Record last verified: 2018-03